Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Histogen stock | $0.99

Learn how to easily invest in Histogen stock.

Histogen Inc
-$0.01 (-0.81%)

Histogen Inc is a biotechnology business based in the US. Histogen shares (HSTO) are listed on the NASDAQ and all prices are listed in US Dollars. Histogen employs 19 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Histogen

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HSTO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Histogen stock price (NASDAQ: HSTO)

Use our graph to track the performance of HSTO stocks over time.

Histogen shares at a glance

Information last updated 2021-07-28.
Latest market close$0.99
52-week range$0.77 - $3.08
50-day moving average $0.96
200-day moving average $1.12
Wall St. target price$4.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.05

Buy Histogen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Histogen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Histogen price performance over time

Historical closes compared with the close of $0.99 from 2021-05-28

1 week (2021-07-25) N/A
1 month (2021-07-02) -3.88%
3 months (2021-05-05) -3.88%
6 months (2021-02-01) N/A
1 year (2020-08-01) N/A
2 years (2019-08-01) N/A
3 years (2018-08-01) N/A
5 years (2016-08-01) N/A

Histogen financials

Revenue TTM $1.5 million
Gross profit TTM $-5,022,000
Return on assets TTM -49.48%
Return on equity TTM -199.73%
Profit margin 0%
Book value $0.63
Market capitalisation $34.5 million

TTM: trailing 12 months

Shorting Histogen shares

There are currently 393,218 Histogen shares held short by investors – that's known as Histogen's "short interest". This figure is 23.4% down from 513,327 last month.

There are a few different ways that this level of interest in shorting Histogen shares can be evaluated.

Histogen's "short interest ratio" (SIR)

Histogen's "short interest ratio" (SIR) is the quantity of Histogen shares currently shorted divided by the average quantity of Histogen shares traded daily (recently around 3.3 million). Histogen's SIR currently stands at 0.12. In other words for every 100,000 Histogen shares traded daily on the market, roughly 120 shares are currently held short.

However Histogen's short interest can also be evaluated against the total number of Histogen shares, or, against the total number of tradable Histogen shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Histogen's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Histogen shares in existence, roughly 10 shares are currently held short) or 0.0126% of the tradable shares (for every 100,000 tradable Histogen shares, roughly 13 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Histogen.

Find out more about how you can short Histogen stock.

Histogen share dividends

We're not expecting Histogen to pay a dividend over the next 12 months.

Have Histogen's shares ever split?

Histogen's shares were split on a 1:10 basis on 26 May 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Histogen shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Histogen shares which in turn could have impacted Histogen's share price.

Histogen overview

Histogen Inc. , a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company's pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. .

Stocks similar to Histogen

Frequently asked questions

What percentage of Histogen is owned by insiders or institutions?
Currently 7.032% of Histogen shares are held by insiders and 3.987% by institutions.
How many people work for Histogen?
Latest data suggests 19 work at Histogen.
When does the fiscal year end for Histogen?
Histogen's fiscal year ends in December.
Where is Histogen based?
Histogen's address is: 10655 Sorrento Valley Road, San Diego, CA, United States, 92121
What is Histogen's ISIN number?
Histogen's international securities identification number is: US43358Y1038

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site